CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition Research Letter

   


Authors: Diamond, E. L.; Francis, J. H.; Lacouture, M. E.; Rotemberg, V.; Yabe, M.; Petrova-Drus, K.; Ulaner, G. A.; Reddy, R.; Abdel-Wahab, O.; Durham, B. H.
Title: CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition
Keywords: genetics; mutation; protein tyrosine kinase; hematologic neoplasms; histiocytosis; receptor protein-tyrosine kinases; hematologic disease; humans; human
Journal Title: Leukemia
Volume: 37
Issue: 8
ISSN: 0887-6924
Publisher: Nature Publishing Group  
Date Published: 2023-08-01
Start Page: 1737
End Page: 1740
Language: English
DOI: 10.1038/s41375-023-01947-4
PUBMED: 37355734
PROVIDER: scopus
PMCID: PMC10400417
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85162920131&doi=10.1038%2fs41375-023-01947-4&partnerID=40&md5=ff7c850c890e0c9898e43547e246f938
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Eli Diamond -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture
  2. Jasmine Helen Francis
    256 Francis
  3. Omar Ibrahim Abdel-Wahab
    573 Abdel-Wahab
  4. Eli Louis Diamond
    202 Diamond
  5. Benjamin Heath Durham
    115 Durham
  6. Veronica Miriam Rotemberg
    92 Rotemberg
  7. Mariko Yabe
    50 Yabe
  8. Kseniya Petrova-Drus
    61 Petrova-Drus
  9. Ryan Padira Reddy
    13 Reddy
Related MSK Work